ovarian cancer - Nursing Case Study
Pathophysiology
• Primary mechanism: Genetic mutations, particularly in BRCA1 and BRCA2 genes, disrupt normal DNA repair processes, leading to uncontrolled cellular proliferation in the ovarian epithelium and tumor development.
• Secondary mechanism: Inflammation due to ovulation-induced epithelial damage creates an environment conducive to malignant transformation by promoting angiogenesis and further genetic instability.
• Key complication: Tumor growth and metastasis often occur within the peritoneal cavity, resulting in ascites, bowel obstruction, and impaired organ function, significantly impacting patient quality of life and prognosis.
Patient Profile
Demographics:
57-year-old female, retired school teacher
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Family history of breast cancer
• Current medications: Metformin 500 mg BID, Lisinopril 10 mg daily, Aspirin 81 mg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Abdominal pain and bloating
• Key symptoms: Persistent pelvic pain, increased abdominal girth, early satiety, fatigue
• Vital signs: Blood pressure 145/90 mmHg, heart rate 102 bpm, respiratory rate 20 breaths per minute, temperature 99.1°F, oxygen saturation 95% on room air
Section 1
During her initial assessment, the patient exhibits signs consistent with further disease progression. Upon physical examination, there is noticeable abdominal distension, and a positive fluid wave test suggests the presence of ascites. The patient's abdomen is tender to palpation, with rebound tenderness indicating possible peritoneal irritation. Her bowel sounds are hypoactive, raising concerns about potential bowel obstruction. In addition to her physical symptoms, the patient reports experiencing worsening fatigue and describes her abdominal bloating as more discomforting, impacting her ability to perform daily activities.
Laboratory results reveal elevated CA-125 levels, suggestive of advanced ovarian cancer. A comprehensive metabolic panel shows mild hyponatremia and hypoalbuminemia, likely due to fluid shifts and malnutrition associated with her condition. Her complete blood count indicates a normocytic anemia, which may be attributed to chronic disease or nutritional deficiencies. Imaging studies, including a CT scan of the abdomen and pelvis, confirm the presence of a sizable pelvic mass with significant peritoneal carcinomatosis, as well as moderate ascites. These findings highlight the need for timely intervention to address both the cancer progression and the symptomatic ascites.
Clinically, the patient's status necessitates a multifaceted approach. Management of her ascites through paracentesis may provide symptomatic relief, while adjustments in her diabetes and hypertension management are crucial to avoid exacerbating her current health status. The interdisciplinary team should consider initiating discussions regarding chemotherapy options, balancing potential benefits with the patient's quality of life. As the case unfolds, the healthcare team must remain vigilant for further complications such as bowel obstruction or infection, which could significantly alter the patient’s treatment trajectory.
Section 2
As the healthcare team continues to monitor the patient's condition, a change in her status becomes increasingly apparent. Over the course of several days, the patient's abdominal discomfort intensifies, and she begins to exhibit signs consistent with partial bowel obstruction. Her abdominal distension increases, accompanied by more pronounced nausea and occasional vomiting, which she describes as bilious. Her bowel sounds have transitioned from hypoactive to nearly absent, suggesting a progression in her gastrointestinal complications.
Vital signs reveal a low-grade fever of 100.8°F, mild tachycardia with a heart rate of 105 beats per minute, and a blood pressure reading of 98/60 mmHg, indicating possible fluid shifts and early signs of sepsis. Laboratory tests show a further decrease in serum sodium to 128 mmol/L and a drop in albumin to 2.8 g/dL, exacerbating concerns about her nutritional status and potential for infection. White blood cell count is slightly elevated at 12,500/mm³, raising suspicion for an infectious process possibly related to the peritoneal irritation or potential bowel perforation.
In response to these developments, the interdisciplinary team prioritizes the stabilization of the patient's condition. Immediate measures include the initiation of intravenous fluid therapy to address hypovolemia and correct electrolyte imbalances. Empirical broad-spectrum antibiotics are started to preemptively manage any underlying infection. The surgical team is consulted for potential decompression of the bowel obstruction, considering both the patient's current symptoms and imaging findings. These interventions set the stage for the next phase of her treatment, which will require close monitoring and decision-making regarding further oncological management and supportive care strategies.
Section 3
As the team continues to monitor the patient, her response to the initial interventions presents a mixed clinical picture. Over the next 24 hours, the patient's abdominal pain lessens slightly, and her nausea becomes more manageable with antiemetics. However, her abdominal distension remains pronounced, and bowel sounds are still nearly absent, suggesting that the bowel obstruction has not resolved. Repeat imaging, including an abdominal CT scan, reveals significant bowel distension with multiple air-fluid levels, consistent with a high-grade obstruction. There is no evidence of free air, ruling out immediate bowel perforation, but the presence of ascites has increased, heightening concerns about tumor progression and further complicating her clinical status.
The patient's vital signs show some improvement with fluid resuscitation: her blood pressure stabilizes at 105/65 mmHg, and her heart rate decreases to 98 beats per minute. Despite these improvements, her low-grade fever persists at 100.5°F, and her white blood cell count remains elevated at 13,200/mm³, suggesting ongoing inflammatory or infectious processes. Laboratory tests reveal a slight improvement in serum sodium to 130 mmol/L, but hypoalbuminemia persists at 2.7 g/dL, indicating continued nutritional challenges. In light of these findings, the team considers the risk of bacterial translocation due to bowel stasis and ascites, which could exacerbate her condition.
Given the complexity of her case, the team is faced with critical decisions regarding her ongoing care. The surgical team deliberates the benefits and risks of proceeding with surgical intervention versus conservative management with nasogastric decompression and continued antibiotic therapy. Oncological input is also crucial, as the progression of ovarian cancer may necessitate a reassessment of her chemotherapeutic regimen. The interdisciplinary team plans a meeting to discuss the next steps, with a focus on balancing the need for aggressive treatment with the patient's overall prognosis and quality of life. This juncture requires careful clinical reasoning to navigate her evolving condition and determine the most appropriate path forward.
Section 4
After the interdisciplinary team meeting, a decision is made to proceed with conservative management in the short term, with close monitoring for any signs of deterioration. The team opts to continue nasogastric decompression and administer broad-spectrum antibiotics to address the risk of bacterial translocation. The oncology team also proposes adjustments to her chemotherapy regimen, considering the potential impact of tumor progression on her bowel obstruction. As part of this plan, the patient receives supportive care aimed at managing her symptoms and optimizing her nutritional status.
Over the next 48 hours, the patient's condition shows mixed responses to the interventions. Her abdominal distension remains significant, and repeat abdominal X-rays confirm that the high-grade obstruction persists, with no significant change in air-fluid levels. However, her vital signs continue to stabilize, with her blood pressure holding steady at 110/70 mmHg and her heart rate further decreasing to 92 beats per minute. Her fever subsides slightly, now fluctuating between 99.8°F and 100.2°F, indicating a partial response to the antibiotic therapy. Her white blood cell count decreases to 12,500/mm³, suggesting a reduction in the inflammatory response, although her hypoalbuminemia remains a concern at 2.6 g/dL, highlighting ongoing nutritional challenges.
Despite these improvements, the patient begins to exhibit signs of increased fatigue and mild confusion, raising concerns about potential electrolyte imbalances or worsening metabolic status. A repeat set of laboratory tests reveals a further drop in serum sodium to 128 mmol/L and a mild increase in serum creatinine to 1.4 mg/dL, indicating declining renal function. These findings prompt the team to re-evaluate her fluid management strategy and consider the potential need for electrolyte replacement therapy. This development underscores the complexity of her case, requiring continued vigilant monitoring and adjustment of her treatment plan to prevent further complications and optimize her quality of life.
Section 5
In light of the patient's increasing fatigue and mild confusion, the medical team decides to prioritize a comprehensive assessment of her electrolyte status and renal function. The latest lab results reveal a further reduction in serum sodium to 126 mmol/L, confirming the onset of hyponatremia, which may be contributing to her neurological symptoms. Additionally, her serum potassium level is found to be slightly elevated at 5.2 mmol/L. This hyperkalemia, coupled with a serum creatinine that has increased to 1.6 mg/dL, suggests a worsening of her renal function, likely exacerbated by ongoing dehydration and potential nephrotoxic effects of her current medication regimen.
Given these findings, the team initiates a more aggressive approach to fluid and electrolyte management. Intravenous fluids are adjusted to include isotonic saline to address the hyponatremia, while careful monitoring of her potassium levels is implemented to prevent further elevation. The potential need for diuretics is weighed cautiously due to her renal status, and a nephrology consult is considered to optimize her fluid balance and prevent progression to acute kidney injury.
These developments highlight the intricate interplay between her oncological needs and the emerging metabolic complications, necessitating close collaboration between oncology, nephrology, and nutrition services. As the team recalibrates her treatment plan, they continue to monitor her cognitive status and renal function closely, ready to pivot her care strategy should her condition evolve further. This vigilant approach aims to stabilize her current complications and maintain her overall quality of life as she continues her battle against ovarian cancer.